DOCSLIB.ORG

Supplementary Table 1. the List of 1,675 All Stages of AD-Related Upregulated Genes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Supplementary Table 1. The list of 1,675 all stages of AD-related upregulated genes Gene ID Gene symbol Gene name 51146 A4GNT ALPHA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE 9625 AATK APOPTOSIS-ASSOCIATED TYROSINE KINASE 19 ABCA1 ATP-BINDING CASSETTE, SUB-FAMILY A (ABC1), MEMBER 1 20 ABCA2 ATP-BINDING CASSETTE, SUB-FAMILY A (ABC1), MEMBER 2 10058 ABCB6 ATP-BINDING CASSETTE, SUB-FAMILY B (MDR/TAP), MEMBER 6 89845 ABCC10 ATP-BINDING CASSETTE, SUB-FAMILY C (CFTR/MRP), MEMBER 10 5826 ABCD4 ATP-BINDING CASSETTE, SUB-FAMILY D (ALD), MEMBER 4 25 ABL1 V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 3983 ABLIM1 ACTIN BINDING LIM PROTEIN 1 30 ACAA1 ACETYL-COENZYME A ACYLTRANSFERASE 1 (PEROXISOMAL 3-OXOACYL-COENZYME A THIOLASE) 35 ACADS ACYL-COENZYME A DEHYDROGENASE, C-2 TO C-3 SHORT CHAIN 8310 ACOX3 ACYL-COENZYME A OXIDASE 3, PRISTANOYL 56 ACRV1 ACROSOMAL VESICLE PROTEIN 1 2180 ACSL1 ACYL-COA SYNTHETASE LONG-CHAIN FAMILY MEMBER 1 86 ACTL6A ACTIN-LIKE 6A 93973 ACTR8 ACTIN-RELATED PROTEIN 8 91 ACVR1B ACTIVIN A RECEPTOR, TYPE IB 8747 ADAM21 ADAM METALLOPEPTIDASE DOMAIN 21 27299 ADAMDEC1 ADAM-LIKE, DECYSIN 1 56999 ADAMTS9 ADAM METALLOPEPTIDASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9 105 ADARB2 ADENOSINE DEAMINASE, RNA-SPECIFIC, B2 (RED2 HOMOLOG RAT) 109 ADCY3 ADENYLATE CYCLASE 3 113 ADCY7 ADENYLATE CYCLASE 7 120 ADD3 ADDUCIN 3 (GAMMA) 125 ADH1C ALCOHOL DEHYDROGENASE 1A (CLASS I), ALPHA POLYPEPTIDE 9370 ADIPOQ ADIPONECTIN, C1Q AND COLLAGEN DOMAIN CONTAINING 165 AEBP1 AE BINDING PROTEIN 1 4299 AFF1 AF4/FMR2 FAMILY, MEMBER 1 173 AFM AFAMIN 79814 AGMAT AGMATINE UREOHYDROLASE (AGMATINASE) 10555 AGPAT2 1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 2 (LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE, BETA) 375790 AGRN AGRIN 185 AGTR1 ANGIOTENSIN II RECEPTOR, TYPE 1 187 AGTRL1 ANGIOTENSIN II RECEPTOR-LIKE 1 25909 AHCTF1 AT HOOK CONTAINING TRANSCRIPTION FACTOR 1 202 AIM1 ABSENT IN MELANOMA 1 203 AK1 ADENYLATE KINASE 1 204 AK2 ADENYLATE KINASE 2 8165 AKAP1 A KINASE (PRKA) ANCHOR PROTEIN 1 11214 AKAP13 LYMPHOID BLAST CRISIS ONCOGENE 10270 AKAP8 A KINASE (PRKA) ANCHOR PROTEIN 8 26993 AKAP8L A KINASE (PRKA) ANCHOR PROTEIN 8-LIKE 10142 AKAP9 A KINASE (PRKA) ANCHOR PROTEIN (YOTIAO) 9 1645 AKR1C1 ALDO-KETO REDUCTASE FAMILY 1, MEMBER C1 (DIHYDRODIOL DEHYDROGENASE 1; 20-ALPHA (3-ALPHA)- HYDROXYSTEROID DEHYDROGENASE) 8644 AKR1C3 ALDO-KETO REDUCTASE FAMILY 1, MEMBER C3 (3-ALPHA HYDROXYSTEROID DEHYDROGENASE, TYPE II) 10000 AKT3 V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 3 (PROTEIN KINASE B, GAMMA) 8854 ALDH1A2 ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A2 224 ALDH3A2 ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER A2 7840 ALMS1 ALSTROM SYNDROME 1 51421 AMOTL2 ANGIOMOTIN LIKE 2 272 AMPD3 ADENOSINE MONOPHOSPHATE DEAMINASE (ISOFORM E) 29882 ANAPC2 ANAPHASE PROMOTING COMPLEX SUBUNIT 2 284 ANGPT1 ANGIOPOIETIN 1 23452 ANGPTL2 ANGIOPOIETIN-LIKE 2 10541 ANP32B ACIDIC (LEUCINE-RICH) NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER B 301 ANXA1 ANNEXIN A1 302 ANXA2 ANNEXIN A2 314 AOC2 AMINE OXIDASE, COPPER CONTAINING 2 (RETINA-SPECIFIC) 162 AP1B1 ADAPTOR-RELATED PROTEIN COMPLEX 1, BETA 1 SUBUNIT 10239 AP3S2 ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA 2 SUBUNIT 9546 APBA3 AMYLOID BETA (A4) PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 3 (X11-LIKE 2) 339 APOBEC1 APOLIPOPROTEIN B MRNA EDITING ENZYME, CATALYTIC POLYPEPTIDE 1 341 APOC1 APOLIPOPROTEIN C-I 346 APOC4 APOLIPOPROTEIN C-IV 23780 APOL2 APOLIPOPROTEIN L, 2 54840 APTX APRATAXIN 358 AQP1 AQUAPORIN 1 (COLTON BLOOD GROUP) 363 AQP6 AQUAPORIN 6, KIDNEY SPECIFIC 8260 ARD1A ARD1 HOMOLOG A, N-ACETYLTRANSFERASE (S. CEREVISIAE) 382 ARF6 ADP-RIBOSYLATION FACTOR 6 55738 ARFGAP1 ADP-RIBOSYLATION FACTOR GTPASE ACTIVATING PROTEIN 1 384 ARG2 ARGINASE, TYPE II 392 ARHGAP1 RHO GTPASE ACTIVATING PROTEIN 1 55114 ARHGAP17 RHO GTPASE ACTIVATING PROTEIN 17 23092 ARHGAP26 RHO GTPASE ACTIVATING PROTEIN 26 395 ARHGAP6 RHO GTPASE ACTIVATING PROTEIN 6 9639 ARHGEF10 RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR (GEF) 10 22899 ARHGEF15 RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR (GEF) 15 27237 ARHGEF16 RHO GUANINE EXCHANGE FACTOR (GEF) 16 23370 ARHGEF18 RHO/RAC GUANINE NUCLEOTIDE EXCHANGE FACTOR (GEF) 18 8289 ARID1A AT RICH INTERACTIVE DOMAIN 1A (SWI- LIKE) 5926 ARID4A AT RICH INTERACTIVE DOMAIN 4A (RBP1-LIKE) 51742 ARID4B AT RICH INTERACTIVE DOMAIN 4B (RBP1- LIKE) 25852 ARMC8 ARMADILLO REPEAT CONTAINING 8 10095 ARPC1B ACTIN RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1B, 41KDA 51593 ARS2 ARS2 PROTEIN 51665 ASB1 ANKYRIN REPEAT AND SOCS BOX-CONTAINING 1 140462 ASB9 ANKYRIN REPEAT AND SOCS BOX-CONTAINING 9 429 ASCL1 ACHAETE-SCUTE COMPLEX-LIKE 1 (DROSOPHILA) 22809 ATF5 ACTIVATING TRANSCRIPTION FACTOR 5 64422 ATG3 ATG3 AUTOPHAGY RELATED 3 HOMOLOG (S. CEREVISIAE) 23192 ATG4B ATG4 AUTOPHAGY RELATED 4 HOMOLOG B (S. CEREVISIAE) 57205 ATP10D ATPASE, CLASS V, TYPE 10D 8992 ATP6V0E1 ATPASE, H+ TRANSPORTING, LYSOSOMAL 9KDA, V0 SUBUNIT E 538 ATP7A ATPASE, CU++ TRANSPORTING, ALPHA POLYPEPTIDE (MENKES SYNDROME) 5205 ATP8B1 ATPASE, CLASS I, TYPE 8B, MEMBER 1 57099 AVEN APOPTOSIS, CASPASE ACTIVATION INHIBITOR 552 AVPR1A ARGININE VASOPRESSIN RECEPTOR 1A 563 AZGP1 ALPHA-2-GLYCOPROTEIN 1, ZINC 8704 B4GALT2 UDP-GAL:BETAGLCNAC BETA 1,4- GALACTOSYLTRANSFERASE, POLYPEPTIDE 2 60468 BACH2 BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 2 572 BAD BCL2-ANTAGONIST OF CELL DEATH 573 BAG1 BCL2-ASSOCIATED ATHANOGENE 54971 BANP BTG3 ASSOCIATED NUCLEAR PROTEIN 11177 BAZ1A BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1A 11176 BAZ2A BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2A 29994 BAZ2B DKFZP434H071 PROTEIN 4059 BCAM BASAL CELL ADHESION MOLECULE (LUTHERAN BLOOD GROUP) 587 BCAT2 BRANCHED CHAIN AMINOTRANSFERASE 2, MITOCHONDRIAL 596 BCL2 B-CELL CLL/LYMPHOMA 2 604 BCL6 B-CELL CLL/LYMPHOMA 6 (ZINC FINGER PROTEIN 51) 605 BCL7A B-CELL CLL/LYMPHOMA 7A 7439 BEST1 VITELLIFORM MACULAR DYSTROPHY 2 (BEST DISEASE, BESTROPHIN) 51283 BFAR BIFUNCTIONAL APOPTOSIS REGULATOR 632 BGLAP BONE GAMMA-CARBOXYGLUTAMATE (GLA) PROTEIN 633 BGN BIGLYCAN 23743 BHMT2 BETAINE-HOMOCYSTEINE METHYLTRANSFERASE 2 274 BIN1 BRIDGING INTEGRATOR 1 55909 BIN3 BRIDGING INTEGRATOR 3 329 BIRC2 BACULOVIRAL IAP REPEAT-CONTAINING 2 27302 BMP10 BONE MORPHOGENETIC PROTEIN 10 55589 BMP2K BMP2 INDUCIBLE KINASE 657 BMPR1A BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IA 8315 BRAP BRCA1 ASSOCIATED PROTEIN 672 BRCA1 BREAST CANCER 1, EARLY ONSET 23774 BRD1 BROMODOMAIN CONTAINING 1 6046 BRD2 BROMODOMAIN CONTAINING 2 8019 BRD3 BROMODOMAIN CONTAINING 3 23476 BRD4 BROMODOMAIN CONTAINING 4 7862 BRPF1 BROMODOMAIN AND PHD FINGER CONTAINING, 1 680 BRS3 BOMBESIN-LIKE RECEPTOR 3 7832 BTG2 BTG FAMILY, MEMBER 2 10950 BTG3 BTG FAMILY, MEMBER 3 10384 BTN3A3 BUTYROPHILIN, SUBFAMILY 3, MEMBER A3 10917 BTNL3 BUTYROPHILIN-LIKE 3 8945 BTRC BETA-TRANSDUCIN REPEAT CONTAINING 745 C11ORF9 CHROMOSOME 11 OPEN READING FRAME 9 57102 C12ORF4 CHROMOSOME 12 OPEN READING FRAME 4 56905 C15ORF39 CHROMOSOME 15 OPEN READING FRAME 39 8131 C16ORF35 CHROMOSOME 16 OPEN READING FRAME 35 115939 C16ORF42 CHROMOSOME 16 OPEN READING FRAME 42 29965 C16ORF5 CHROMOSOME 16 OPEN READING FRAME 5 753 C18ORF1 CHROMOSOME 18 OPEN READING FRAME 1 51029 C1ORF121 CHROMOSOME 1 OPEN READING FRAME 121 81627 C1ORF25 CHROMOSOME 1 OPEN READING FRAME 25 715 C1R COMPLEMENT COMPONENT 1, R SUBCOMPONENT 716 C1S COMPLEMENT COMPONENT 1, S SUBCOMPONENT 27296 C20ORF10 CHROMOSOME 20 OPEN READING FRAME 10 51526 C20ORF111 CHROMOSOME 20 OPEN READING FRAME 111 79144 C20ORF149 CHROMOSOME 20 OPEN READING FRAME 149 55257 C20ORF20 CHROMOSOME 20 OPEN READING FRAME 20 55317 C20ORF29 CHROMOSOME 20 OPEN READING FRAME 29 25980 C20ORF4 CHROMOSOME 20 OPEN READING FRAME 4 755 C21ORF2 CHROMOSOME 21 OPEN READING FRAME 2 56245 C21ORF62 CHROMOSOME 21 OPEN READING FRAME 62 54149 C21ORF91 CHROMOSOME 21 OPEN READING FRAME 91 6936 C2ORF3 CHROMOSOME 2 OPEN READING FRAME 3 51161 C3ORF18 CHROMOSOME 3 OPEN READING FRAME 18 56941 C3ORF37 CHROMOSOME 3 OPEN READING FRAME 37 23272 C3ORF63 CHROMOSOME 3 OPEN READING FRAME 63 721 C4B COMPLEMENT COMPONENT 4B (CHIDO BLOOD GROUP) 8603 C4ORF8 CHROMOSOME 4 OPEN READING FRAME 8 727 C5 COMPLEMENT COMPONENT 5 10826 C5ORF4 CHROMOSOME 5 OPEN READING FRAME 4 730 C7 COMPLEMENT COMPONENT 7 84909 C9ORF3 CHROMOSOME 9 OPEN READING FRAME 3 90477 C9ORF33 CHROMOSOME 9 OPEN READING FRAME 33 9413 C9ORF61 CHROMOSOME 9 OPEN READING FRAME 61 11094 C9ORF7 CHROMOSOME 9 OPEN READING FRAME 7 759 CA1 CARBONIC ANHYDRASE I 56997 CABC1 CHAPERONE, ABC1 ACTIVITY OF BC1 COMPLEX LIKE (S. POMBE) 773 CACNA1A CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA 1A SUBUNIT 8913 CACNA1G CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA 1G SUBUNIT 800 CALD1 CALDESMON 1 91860 CALML4 CALMODULIN-LIKE 4 124583 CANT1 CALCIUM ACTIVATED NUCLEOTIDASE 1 825 CAPN3 CALPAIN 3, (P94) 10498 CARM1 COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 22794 CASC3 CANCER SUSCEPTIBILITY CANDIDATE 3 8573 CASK CALCIUM/CALMODULIN-DEPENDENT SERINE PROTEIN KINASE (MAGUK FAMILY) 57513 CASKIN2 CASK INTERACTING PROTEIN 2 836 CASP3 CASPASE 3, APOPTOSIS-RELATED CYSTEINE PEPTIDASE 837 CASP4 CASPASE 4, APOPTOSIS-RELATED CYSTEINE PEPTIDASE 839 CASP6 CASPASE 6, APOPTOSIS-RELATED CYSTEINE PEPTIDASE 842 CASP9 CASPASE 9, APOPTOSIS-RELATED CYSTEINE PEPTIDASE 831 CAST CALPASTATIN 865 CBFB CORE-BINDING FACTOR, BETA SUBUNIT 868 CBLB CAS-BR-M (MURINE) ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE B 28952 CCDC22 COILED-COIL DOMAIN CONTAINING 22 29080 CCDC59 COILED-COIL DOMAIN CONTAINING 59 26112 CCDC69 COILED-COIL DOMAIN CONTAINING 69 26093 CCDC9 COILED-COIL DOMAIN CONTAINING 9 54535 CCHCR1 COILED-COIL ALPHA-HELICAL ROD PROTEIN 1 896 CCND3 CYCLIN D3 10983 CCNI CYCLIN I 2826 CCR10 CHEMOKINE (C-C MOTIF) RECEPTOR 10 25819 CCRN4L
Recommended publications
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB

    Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB

    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
  • RT² Profiler PCR Array (384-Well Format) Human Apoptosis 384HT

    RT² Profiler PCR Array (384-Well Format) Human Apoptosis 384HT

    RT² Profiler PCR Array (384-Well Format) Human Apoptosis 384HT Cat. no. 330231 PAHS-3012ZE For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 7900HT (384-well block), Format E ViiA™ 7 (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (384-well block) Format G Description The Human Apoptosis RT² Profiler PCR Array profiles the expression of 370 key genes involved in apoptosis, or programmed cell death. The array includes the TNF ligands and their receptors; members of the bcl-2 family, BIR (baculoviral IAP repeat) domain proteins, CARD domain (caspase recruitment domain) proteins, death domain proteins, TRAF (TNF receptor-associated factor) domain proteins and caspases. These 370 genes are also grouped by their functional contribution to apoptosis, either anti-apoptosis or induction of apoptosis. Using real-time PCR, you can easily and reliably analyze expression of a focused panel of genes related to apoptosis with this array. For further details, consult the RT² Profiler PCR Array Handbook. Sample & Assay Technologies Shipping and storage RT² Profiler PCR Arrays in formats E and G are shipped at ambient temperature, on dry ice, or blue ice packs depending on destination and accompanying products. For long term storage, keep plates at –20°C. Note: Ensure that you have the correct RT² Profiler PCR Array format for your real-time cycler (see table above). Note: Open the package and store the products appropriately immediately
  • Identification of Novel Pathways That Promote Anoikis Through Genome-Wide Screens

    Identification of Novel Pathways That Promote Anoikis Through Genome-Wide Screens

    University of Massachusetts Medical School eScholarship@UMMS GSBS Dissertations and Theses Graduate School of Biomedical Sciences 2016-10-14 Identification of Novel Pathways that Promote Anoikis through Genome-wide Screens Victoria E. Pedanou University of Massachusetts Medical School Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss Part of the Biology Commons, and the Cancer Biology Commons Repository Citation Pedanou VE. (2016). Identification of Novel Pathways that Promote Anoikis through Genome-wide Screens. GSBS Dissertations and Theses. https://doi.org/10.13028/M27G6D. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/889 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. i TITLE PAGE IDENTIFICATION OF NOVEL PATHWAYS THAT PROMOTE ANOIKIS THROUGH GENOME-WIDE SCREENS A Dissertation Presented By VICTORIA ELIZABETH PEDANOU Submitted to the Faculty of the University of Massachusetts Graduate School of Biomedical Sciences, Worcester in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY OCTOBER 14TH, 2016 CANCER BIOLOGY ii SIGNATURE PAGE IDENTIFICATION OF NOVEL PATHWAYS THAT PROMOTE ANOIKIS THROUGH GENOME-WIDE SCREENS A Dissertation Presented By VICTORIA ELIZABETH PEDANOU This work was undertaken in the Graduate School of Biomedical Sciences Cancer Biology The signature of the Thesis Advisor signifies validation of Dissertation content ___________________________ Michael R. Green, Thesis Advisor The signatures of the Dissertation Defense Committee signify completion and approval as to style and content of the Dissertation __________________________________ Eric H.
  • Cytokine Nomenclature

    Cytokine Nomenclature

    RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B
  • Stimulating the Expression of Sphingosine Kinase 1 (Sphk1) Is Bene�Cial to Reduce Acrylamide-Induced Nerve Cell Damage

    Stimulating the Expression of Sphingosine Kinase 1 (Sphk1) Is BeneCial to Reduce Acrylamide-Induced Nerve Cell Damage

    Stimulating the Expression of Sphingosine Kinase 1 (SphK1) is Benecial to Reduce Acrylamide-Induced Nerve Cell Damage Yong-Hui Wu ( [email protected] ) Harbin Medical University https://orcid.org/0000-0002-4838-2947 Sheng-Yuan Wang Harbin Medical University Xiao-Li Wang Harbin Medical University Rui Xin Harbin Medical University Ye Xin Harbin Medical University Rui Wang Harbin Medical University Kun Ma Harbin Medical University Cui-Ping Yu Harbin Medical University Dan Zhang Harbin Medical University Xiao-Rong Zhou Harbin Medical University Wei-Wei Ma Harbin Medical University Chao Wang Harbin Medical University Research Keywords: Acrylamide, SphKl, Neurotoxicity, Apoptosis, MAPK pathway Posted Date: September 28th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-80914/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Stimulating the expression of sphingosine kinase 1 (SphK1) is beneficial to reduce acrylamide-induced nerve cell damage Sheng-Yuan Wang1, Xiao-Li Wang1, Rui Xin1, Ye Xin1, Rui Wang1, Kun Ma2, Cui-Ping Yu1, Dan Zhang1, Xiao-Rong Zhou1, Wei-Wei Ma3, Chao Wang4, Yong-Hui Wu1* 1 Department of Occupational Health, Public Health College, Harbin Medical University, Harbin, P. R. 2 Department of Hygienic Toxicology, Public Health College, Harbin Medical University, Harbin, P. R. 3 Harbin Railway Center for Disease Control and Prevention, Harbin, P. R. 4 Health Commission of Heilongjiang Province. * Address correspondence to this author at: The Department of Occupational Health, Public Health College, Harbin Medical University, 157 Baojian Road, Nan gang District, Harbin, People’s Republic of China 150086. Phone: +86-451-8750-2827, Fax: +86-451-8750-2827, E-mail: [email protected].
  • Table 2. Significant

    Table 2. Significant

    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
  • Mutations in EDA and EDAR Genes in a Large Mexican Hispanic Cohort with Hypohidrotic Ectodermal Dysplasia

    Mutations in EDA and EDAR Genes in a Large Mexican Hispanic Cohort with Hypohidrotic Ectodermal Dysplasia

    Letter to the Editor http://dx.doi.org/10.5021/ad.2015.27.4.474 Mutations in EDA and EDAR Genes in a Large Mexican Hispanic Cohort with Hypohidrotic Ectodermal Dysplasia Julio C Salas-Alanis1,2, Eva Wozniak3, Charles A Mein3, Carola C Duran Mckinster4, Jorge Ocampo-Candiani1, David P Kelsell5, Rong Hua6, Maria L Garza-Rodriguez7, Keith A Choate6, Hugo A Barrera Saldaña7,8 1Dermatology Department, Hospital Universitario, Universidad Autonoma de Nuevo Leon, 2Basic Science Department, Medicine School, Universidad de Monterrey, Monterrey, NL, Mexico, 3Barts and the London Genome Centre, John Vane Science Centre, Barts and the London School of Medicine and Dentistry, University of London, London, United Kingdom, 4Instituto Nacional de Pediatria, Coyoacan, CP, Mexico, 5Centre for Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 6Departments of Dermatology, Genetics, and Pathology, Yale University School of Medicine, New Haven, CT, USA, 7Facultad de Medicina, Departamento de Bioquímica y Medicina Molecular, Universidad Autonoma de Nuevo Leon,8Vitagenesis, Monterrey, NL, Mexico Dear Editor: cludes dryness of the skin, eyes, airways, and mucous Ectodermal dysplasias (ED) encompass nearly 200 differ- membranes, as well as other ectodermal defects and, in ent genetic conditions identified by the lack, or dysgenesis, some cases, fever, seizures, and rarely, death. of at least two ectodermal derivatives, such as hair, nails, XL-HED is caused by mutations in the EDA gene, located teeth, and sweat glands. Hypohidrotic/anhidrotic ED (HED) on chromosome Xq12-q13.1, which encodes a signaling is the most frequent form of ED and it can be inherited as molecule of the tumor necrosis factor (TNF) superfamily.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Functional Analysis of Ectodysplasin-A Mutations in X-Linked Non-Syndromic Hypodontia and Possible Involvement of X-Chromosome Inactivation

    Functional Analysis of Ectodysplasin-A Mutations in X-Linked Non-Syndromic Hypodontia and Possible Involvement of X-Chromosome Inactivation

    Functional analysis of Ectodysplasin-A mutations in X-linked non-syndromic hypodontia and possible involvement of X-chromosome inactivation Yuhua Pan ( [email protected] ) Southern Medical University https://orcid.org/0000-0001-8039-1627 Ting Lu Southern Medical University Ling Peng Southern Medical University Qi Zeng Southern Medical University Xiangyu Huang Southern Medical University Buling Wu Southern Medical University Fu Xiong Southern Medical University Research Article Keywords: ectodysplasin-A, dental pulp stem cells, X chromosome inactivation, tooth agenesis, odontogenic differentiation Posted Date: August 13th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-602940/v2 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/17 Abstract Background: Mutations of the Ectodysplasin-A (EDA) gene are generally associated with syndrome hypohidrotic ectodermal dysplasia or non-syndromic tooth agenesis. The inuence of EDA mutations on dentinogenesis and odontoblast differentiation have not been reported. The aim of this study was to identify genetic clues for the causes of familial non-syndromic oligodontia and explore the underlying mechanisms involved, while focusing on the role of human dental pulp stem cells (hDPSCs). Materials and Methods: Candidate gene sequences were obtained by PCR amplication and Sanger sequencing. Functional analysis was conducted, and the pathogenesis associated with EDA mutations in hDPSCs was investigated to explore the impact of the identied mutation on the phenotype. Capillary electrophoresis (CE) was used to detect X chromosome inactivation (XCI) in the blood of female carriers. Results: In this study, we identied an EDA mutation in a Chinese familythe missense mutation c.1013C>T (Thr338Met).
  • Leigh Syndrome: One Disorder, More Than 75 Monogenic Causes

    Leigh Syndrome: One Disorder, More Than 75 Monogenic Causes

    Title: Leigh Syndrome: One disorder, more than 75 monogenic causes Running head: Leigh Syndrome: One disorder, many genes Author list: Nicole J. Lake, MSc,1,2 Alison G. Compton, PhD,1,2 Shamima Rahman, MD, PhD,3 and David R. Thorburn, PhD1,2,4 Affiliations: From the 1Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia; 2Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia; 3Mitochondrial Research Group, Genetics and Genomic Medicine, Institute of Child Health, University College London and Metabolic Unit, Great Ormond Street Hospital, London, United Kingdom; 4Victorian Clinical Genetic Services, Royal Children's Hospital, Melbourne, Victoria, Australia. Corresponding author: Prof. David Thorburn Email [email protected] Telephone +61 3 8341 6235 Fax +61 3 8341 6212 Address Murdoch Childrens Research Institute, The Royal Children’s Hospital, 50 Flemington Rd, Parkville, Victoria, 3052, Australia Number of characters in the title and running head: 51 and 35, respectively Number of words in the abstract (107), and the body of manuscript not including abstract (4877) Number of figures (3), colour figures (1/3), and tables (3) 1 Abstract Leigh syndrome is the most common pediatric presentation of mitochondrial disease. This neurodegenerative disorder is genetically heterogeneous, and to date pathogenic mutations in more than 75 genes have been identified, encoded by two genomes (mitochondrial and nuclear). More than a third of these disease genes have been characterized in the last 5 years alone, reflecting the significant advances made in understanding its etiological basis. We review the diverse biochemical and genetic etiology of Leigh syndrome and associated clinical, neuroradiological and metabolic features that can provide clues for diagnosis.
  • Lipid Metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives

    Lipid Metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives

    cancers Review Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives 1, 1, 1 2 1 Laurence Pellerin y, Lorry Carrié y , Carine Dufau , Laurence Nieto , Bruno Ségui , 1,3 1, , 1, , Thierry Levade , Joëlle Riond * z and Nathalie Andrieu-Abadie * z 1 Centre de Recherches en Cancérologie de Toulouse, Equipe Labellisée Fondation ARC, Université Fédérale de Toulouse Midi-Pyrénées, Université Toulouse III Paul-Sabatier, Inserm 1037, 2 avenue Hubert Curien, tgrCS 53717, 31037 Toulouse CEDEX 1, France; [email protected] (L.P.); [email protected] (L.C.); [email protected] (C.D.); [email protected] (B.S.); [email protected] (T.L.) 2 Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Toulouse III Paul-Sabatier, UMR 5089, 205 Route de Narbonne, 31400 Toulouse, France; [email protected] 3 Laboratoire de Biochimie Métabolique, CHU Toulouse, 31059 Toulouse, France * Correspondence: [email protected] (J.R.); [email protected] (N.A.-A.); Tel.: +33-582-7416-20 (J.R.) These authors contributed equally to this work. y These authors jointly supervised this work. z Received: 15 September 2020; Accepted: 23 October 2020; Published: 27 October 2020 Simple Summary: Melanoma is a devastating skin cancer characterized by an impressive metabolic plasticity. Melanoma cells are able to adapt to the tumor microenvironment by using a variety of fuels that contribute to tumor growth and progression. In this review, the authors summarize the contribution of the lipid metabolic network in melanoma plasticity and aggressiveness, with a particular attention to specific lipid classes such as glycerophospholipids, sphingolipids, sterols and eicosanoids.
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase